Literature DB >> 23093778

Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.

Yukti Choudhury1, Felix Chang Tay, Dang Hoang Lam, Edwin Sandanaraj, Carol Tang, Beng-Ti Ang, Shu Wang.   

Abstract

In the human brain, microRNAs (miRNAs) from the microRNA-376 (miR-376) cluster undergo programmed "seed" sequence modifications by adenosine-to-inosine (A-to-I) editing. Emerging evidence suggests a link between impaired A-to-I editing and cancer, particularly in high-grade gliomas. We hypothesized that disruption of A-to-I editing alters expression of genes regulating glioma tumor phenotypes. By sequencing the miR-376 cluster, we show that the overall miRNA editing frequencies were reduced in human gliomas. Specifically in high-grade gliomas, miR-376a* accumulated entirely in an unedited form. Clinically, a significant correlation was found between accumulation of unedited miR-376a* and the extent of invasive tumor spread as measured by magnetic resonance imaging of patient brains. Using both in vitro and orthotopic xenograft mouse models, we demonstrated that the unedited miR-376a* promoted glioma cell migration and invasion, while the edited miR-376a* suppressed these features. The effects of the unedited miR-376a* were mediated by its sequence-dependent ability to target RAP2A and concomitant inability to target AMFR. Thus, the tumor-dependent introduction of a single base difference in the miR-376a* sequence dramatically alters the selection of its target genes and redirects its function from inhibiting to promoting glioma cell invasion. These findings uncover a new mechanism of miRNA deregulation and identify unedited miR-376a* as a potential therapeutic target in glioblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093778      PMCID: PMC3484441          DOI: 10.1172/JCI62925

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

Review 2.  Posttranscriptional regulation of microRNA biogenesis in animals.

Authors:  Haruhiko Siomi; Mikiko C Siomi
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

3.  Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice.

Authors:  R Brusa; F Zimmermann; D S Koh; D Feldmeyer; P Gass; P H Seeburg; R Sprengel
Journal:  Science       Date:  1995-12-08       Impact factor: 47.728

Review 4.  Molecular diversity through RNA editing: a balancing act.

Authors:  Sanaz Farajollahi; Stefan Maas
Journal:  Trends Genet       Date:  2010-04-13       Impact factor: 11.639

5.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.

Authors:  Shogo Ishiuchi; Keisuke Tsuzuki; Yukari Yoshida; Nobuaki Yamada; Norikazu Hagimura; Haruo Okado; Akiko Miwa; Hideyuki Kurihara; Yoichi Nakazato; Masaru Tamura; Tomio Sasaki; Seiji Ozawa
Journal:  Nat Med       Date:  2002-08-12       Impact factor: 53.440

7.  The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton.

Authors:  Kiyohito Taira; Masato Umikawa; Kimiko Takei; Bat-Erdene Myagmar; Manabu Shinzato; Noriko Machida; Hiroshi Uezato; Shigeo Nonaka; Ken-ichi Kariya
Journal:  J Biol Chem       Date:  2004-09-01       Impact factor: 5.157

Review 8.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 9.  A-to-I RNA editing and cancer: from pathology to basic science.

Authors:  Angela Gallo; Silvia Galardi
Journal:  RNA Biol       Date:  2008-07-05       Impact factor: 4.652

10.  Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.

Authors:  Caterina Cenci; Rita Barzotti; Federica Galeano; Sandro Corbelli; Rossella Rota; Luca Massimi; Concezio Di Rocco; Mary A O'Connell; Angela Gallo
Journal:  J Biol Chem       Date:  2008-01-04       Impact factor: 5.157

View more
  89 in total

1.  Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.

Authors:  Kebria Hezaveh; Andreas Kloetgen; Stephan H Bernhart; Kunal Das Mahapatra; Dido Lenze; Julia Richter; Andrea Haake; Anke K Bergmann; Benedikt Brors; Birgit Burkhardt; Alexander Claviez; Hans G Drexler; Roland Eils; Siegfried Haas; Steve Hoffmann; Dennis Karsch; Wolfram Klapper; Kortine Kleinheinz; Jan Korbel; Helene Kretzmer; Markus Kreuz; Ralf Küppers; Chris Lawerenz; Ellen Leich; Markus Loeffler; Luisa Mantovani-Loeffler; Cristina López; Alice C McHardy; Peter Möller; Marius Rohde; Philip Rosenstiel; Andreas Rosenwald; Markus Schilhabel; Matthias Schlesner; Ingrid Scholz; Peter F Stadler; Stephan Stilgenbauer; Stéphanie Sungalee; Monika Szczepanowski; Lorenz Trümper; Marc A Weniger; Reiner Siebert; Arndt Borkhardt; Michael Hummel; Jessica I Hoell
Journal:  Haematologica       Date:  2016-07-06       Impact factor: 9.941

2.  PTBP1 induces ADAR1 p110 isoform expression through IRES-like dependent translation control and influences cell proliferation in gliomas.

Authors:  Bin Yang; Peishan Hu; Xihua Lin; Wei Han; Liyuan Zhu; Xiaochao Tan; Fei Ye; Guanzhou Wang; Fan Wu; Bin Yin; Zhaoshi Bao; Tao Jiang; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  Cell Mol Life Sci       Date:  2015-06-06       Impact factor: 9.261

Review 3.  A critical analysis of codon optimization in human therapeutics.

Authors:  Vincent P Mauro; Stephen A Chappell
Journal:  Trends Mol Med       Date:  2014-09-25       Impact factor: 11.951

4.  Comprehensive analysis of human small RNA sequencing data provides insights into expression profiles and miRNA editing.

Authors:  Jing Gong; Yuliang Wu; Xiantong Zhang; Yifang Liao; Vusumuzi Leroy Sibanda; Wei Liu; An-Yuan Guo
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

5.  MicroRNAs: Editing changes the meaning.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

6.  RNA editing enters the limelight in cancer.

Authors:  Angela Gallo
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

7.  ADAR1 promotes robust hypoxia signaling via distinct regulation of multiple HIF-1α-inhibiting factors.

Authors:  Chung-Pei Ma; Hsuan Liu; Ian Yi-Feng Chang; Wan-Cheng Wang; Yi-Tung Chen; Shao-Min Wu; Hui-Wen Chen; Yu-Ping Kuo; Chieh-Tien Shih; Chuan-Yun Li; Bertrand Chin-Ming Tan
Journal:  EMBO Rep       Date:  2019-04-04       Impact factor: 8.807

8.  Splicing variants of ADAR2 and ADAR2-mediated RNA editing in glioma.

Authors:  Yao Fu; Xingli Zhao; Zhaohui Li; Jun Wei; Yu Tian
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

9.  Micro-editing mistake translates into a devastating brain tumor.

Authors:  Dan Dominissini; Ninette Amariglio; Gideon Rechavi
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 10.  Hypoxia: a master regulator of microRNA biogenesis and activity.

Authors:  Shriram Nallamshetty; Stephen Y Chan; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2013-05-24       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.